Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0000805928-23-000138

Chief R&D Officer returned 1,403 shares (to the company)

  • Chief R&D Officer acquired 2,571 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Scopelianos Angelo Chief R&D Officer 2023-07-18 Grant or award +2,571 38,372 D: show line 1 in the form
Scopelianos Angelo Chief R&D Officer 2023-10-13 Returned to the company −1,403 $4.04 $5,668 36,969 D: show line 2 in the form
Loading xslF345X05/wk-form4_1697243312.xml…